Viewing Study NCT06238466


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2025-12-27 @ 3:04 PM
Study NCT ID: NCT06238466
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-09
First Post: 2024-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-01-16
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-02
Completion Date Type: ESTIMATED
First Submit Date: 2024-01-25
First Submit QC Date: None
Study First Post Date: 2024-02-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-08
Last Update Post Date: 2025-09-09
Last Update Post Date Type: ESTIMATED